A post-hoc analysis of data from two clinical trials showed that nano-encapsulated sirolimus with pegylated-adricase (NASP) may be effective for promoting tophus resolution and lowering serum uric acid in patients with uncontrolled gout.
FDA Approves Obinutuzumab for Lupus Nephritis
Based on data from multiple clinical trials, the FDA has approved obinutuzumab for the treatment of adults with lupus nephritis in combination with standard therapy.
Hip Replacements at 14,000 Feet: A Joint Doctor with Joint Disease, Part 2
Dr. Sam Shapiro writes about her recovery from total hip arthroplasty, detailing what “recovering well with no post-operative complications” really meant and her experience hiking in the Himalayas with a new hip.
Clinical Manifestations of VEXAS
Anderson et al. studied genetic data on more than 190,000 participants and found 23 who had genetic variants in the UBA1 gene, which is associated with VEXAS.
RA Research Presented at ACR Convergence 2025 in Focus
This synopsis of research into rheumatoid arthritis highlights key areas presented at ACR Convergence 2025, including strategies to delay or prevent RA, emerging mechanisms of action in RA treatment, and the growing role of AI in advancing RA research and clinical care.
The Promise of Hope in Lupus Nephritis
Explore the latest lupus nephritis advances in this supplement, covering CAR-T therapy, obinutuzumab data & new diagnostic tools.
Insights into SLE & Lupus Nephritis From the 2025 Review Course
Review expert strategies & clinical pearls for managing SLE & lupus nephritis. Get therapeutic updates from the ACR’s 2025 Review Course.
Lupus Nephritis: A Serious Manifestation of Systemic Lupus Erythematosus
This review highlights some of the many abstracts on lupus nephritis research presented at ACR Convergence 2025. They demonstrate advances made on early recognition of the condition, as well as offering some hope in terms of achieving better outcomes.
Reflections on B Cells in SLE & Lupus Nephritis
At the Dubois Memorial Lecture presented at ACR Convergence 2025, Shaun Jackson, MD, PhD, discussed the evolving understanding of the role of B cells in SLE.
Hydroxychloroquine Remains a Mainstay in Lupus Nephritis
New data: HCQ reduces risk of eGFR decline by 61–73% & slows kidney function loss. Early initiation is critical for renal health in lupus nephritis.
- 1
- 2
- 3
- …
- 331
- Next Page »